Recent Updates
Recently added Catalysts
OM Negative Sentiment Score: 25/100

Outset Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM

Key Takeaway: Outset Medical, Inc. is being sued for alleged securities law violations related to its Tablo dialysis products. The class action complaint claims that the company made misleading statements about the approval and marketing of these devices, which are not fully sanctioned by the FDA. Shareholders who purchased shares during the class period from August 1, 2022, to August 7, 2024, are encouraged to contact The Gross Law Firm for potential lead plaintiff appointments. The deadline for registering in the lawsuit is October 28, 2024.

Market Sentiment Analysis

CONCERNS & RISKS

  • Outset Medical is facing a lawsuit for securities law violations.
  • Allegations include the misleading marketing of Tablo products not approved by the FDA.
  • There are risks that Outset may need to halt sales of Tablo products pending FDA approval of additional indications.
  • The company's revenue growth is likely to be adversely affected due to these issues.

Full Press Release Details

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Outset Medical, Inc. (NASDAQ: OM).
Shareholders who purchased shares of OM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: August 1, 2022 to August 7, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) the Tablo products, its primary devices used in dialysis care, were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA; (2) as a result, Outset Medical was reasonably likely to submit an additional 510(k) application for the Tablo products; (3) there was a substantial risk that the Company would cease sales of the Tablo products pending FDA approval of additional indications; (4) Outset Medical lacked the sales team and process to execute on the ramp of Tablo sales; (5) as a result of the foregoing, the Company’s revenue growth would be adversely impacted; and (6) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
DEADLINE: October 28, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/outset-medical-loss-submission-form/?id=107043&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of OM during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is October 28, 2024. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
15 West 38th Street, 12th floor
Phone: (646) 453-8903

Tags

Frequently Asked Questions

What period does the Outset Medical class action cover?

The class period for Outset Medical covers from August 1, 2022, to August 7, 2024.

What allegations are made against Outset Medical?

Allegations include false marketing of Tablo products and failure to secure FDA approvals.

What is the deadline to register as a lead plaintiff?

The deadline to seek lead plaintiff status is October 28, 2024.

Is there a cost to participate in this class action?

There is no cost or obligation to participate in this class action.

What benefits do registered shareholders receive?

Registered shareholders receive status updates through portfolio monitoring software.

Last updated: Oct 8, 2024